395 Assessing imputation methods with the lebrikizumab clinical trial program
Year: 2023
Type: article
Source: British Journal of Dermatology
Institutions: University of Southern California, George Washington University, University of Copenhagen, Bispebjerg Hospital, Salford Royal NHS Foundation Trust, University of Manchester, NIHR Manchester Biomedical Research Centre, Trinity College Dublin, Eli Lilly (United States), Almirall (Spain), Oregon Health & Science University
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W4381383526
